finance.yahoo.com Earnings
Traws Pharma shares rise after Q2 loss comes in better than expected
Medical research: syringe, bottles and mask ©Bicanski Traws Pharma Inc. (NASDAQ:TRAW) shares gained 3.9% in pre-market trading on Monday after the clinical-stage biopharmaceutical company reported a second-quarter loss that was narrower than Wall Street had anticipated. For the quarter ended June 30, 2026, Traws posted an adjusted loss of $0.16 per share, comfortably beating the analyst consensus estimate …